EQUALINE TRIPLE ANTIBIOTIC- bacitracin zinc, neomycin sulfate, and polymyxin b sulfate ointment

equaline by

Drug Labeling and Warnings

equaline by is a Otc medication manufactured, distributed, or labeled by Supervalu Inc, Taro Pharmaceuticals U.S.A., Inc., Taro Pharmaceuticals Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Drug Facts

ACTIVE INGREDIENT

Active ingredient (each gram contains)	Purpose
Bacitracin zinc 400 units	First aid antibiotic
Neomycin sulfate 3.5 mg	First aid antibiotic
Polymyxin B sulfate 5,000 units	First aid antibiotic

Uses

first aid to help prevent infection in

• minor cuts
• scrapes
• burns

Warnings

For external use only

Do not use

• in the eyes
• over large areas of the body
• if you are allergic to any of the ingredients
• longer than 1 week

Ask a doctor before use

• on deep or puncture wounds, animal bites, or serious burns

Stop use and ask a doctor if

• condition persists or gets worse
• a rash or other allergic reaction develops

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• clean the affected area and dry thoroughly
• apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily
• may be covered with a sterile bandage

Other information

• store at controlled room temperature
• see carton or tube crimp for lot number and expiration date

Inactive ingredients

white petrolatum

SPL UNCLASSIFIED SECTION

Distributed by
Albertsons, Inc.
Boise, Idaho 83726

PRINCIPAL DISPLAY PANEL - 14.2 g Tube Carton

equaline™

compare to Neosporin®
active ingredients*

first aid antibiotic
triple antibiotic ointment

polymyxin B sulfate bacitracin zinc
neomycin sulfate

NET WT 0.5 OZ (14.2 g)

INGREDIENTS AND APPEARANCE

EQUALINE   TRIPLE ANTIBIOTIC
bacitracin zinc, neomycin sulfate, and polymyxin b sulfate ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 41163-016
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Bacitracin zinc (UNII: 89Y4M234ES) (Bacitracin - UNII:58H6RWO52I)	Bacitracin	400 [iU]  in 1 g
Neomycin sulfate (UNII: 057Y626693) (Neomycin - UNII:I16QD7X297)	Neomycin	3.5 mg  in 1 g
Polymyxin B sulfate (UNII: 19371312D4) (Polymyxin B - UNII:J2VZ07J96K)	Polymyxin B	5000 [iU]  in 1 g

Inactive Ingredients
Ingredient Name	Strength
petrolatum (UNII: 4T6H12BN9U)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 41163-016-01	1 in 1 CARTON
1		14.2 g in 1 TUBE
2	NDC: 41163-016-02	1 in 1 CARTON
2		28.4 g in 1 TUBE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part333B	12/14/1995

Labeler - Supervalu Inc (006961411)

Registrant - Taro Pharmaceuticals U.S.A., Inc. (145186370)

Establishment
Name	Address	ID/FEI	Business Operations
Taro Pharmaceuticals Inc.		206263295	MANUFACTURE(41163-016)